12 July 2019
The TGA (Therapeutic Goods Administration) has notified manufacturers that certain textured breast implants may be removed from the market (cancelled) and others may be suspended for 6 months for review depending on the nature of the texturing of their surface.
This is a notice of intent only and nothing has changed in legislation at the present. The breast implant manufacturers will have util the 24th of July to respond to this proposal. The TGA is responding to international scientific papers, including many from Australia, which show a possible link between the degree of texturing of an implant and the risk of developing a Breast Implant Associated Anaplastic Large Cell Lymphoma. (BIA: ALCL) Until the TGA announce their final decision, textured implants and tissue expanders are available for insertion. ASPS encourage their members to consider the least textured implant that will achieve a satisfactory result for their patient.